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Background: Thyrotoxicosis is well known to cause tachyarrhythmias. High degree atrioventricular (AV) and sinoatrial (SA) blocks are a 
documented but often unrecognized manifestation of hyperthyroidism.
case:  30 year old male with history of untreated hyperthyroidism, lost to follow up, presented with bilateral upper and lower extremity 
weakness. Physical exam was significant for tachycardia with pulse rate 102 per minute and diffuse generalized muscle weakness. 
Laboratory studies revealed Potassium of 1.7mmol/L, TSH was less than 0.02mIU/mL, free T4 4.6ng/dL and free T3 11.4pg/mL. 
Thyrotropin antibodies were elevated at 26.92 IU/L consistent with Grave’s disease. Electrocardiogram (ECG) showed sinus rhythm with 
2nd degree AV block (Mobitz I) and prolonged QTc (578 milliseconds).
decision Making:  Given that the patient presented with muscle weakness, severe hypokalemia and abnormal thyroid function tests 
indicating thyrotoxicosis, our diagnosis was Thyrotoxic periodic paralysis. Mobitz I AV block was thought to be related to hyperthyroidism 
and possibly electrolyte abnormality. The exact cause of heart block in hyperthyroidism is unknown and several mechanisms have been 
proposed. Focal myocarditis around the AV node and conduction system has been noted in autopsies. Elevated T3 and electrolyte 
abnormalities may also have a contributing effect. The patient was started on methimazole and hypokalemia was cautiously corrected. 
Most importantly beta blockers were not started immediately to avoid worsening heart block despite its routine use in hyperthyroid states. 
There was a rapid improvement in his symptoms with resolution of heart block and QT prolongation on the ECG by Day 2. Beta-blockers 
were initiated on Day 3 for hyperthyroidism without recurrence of heart block.
conclusion:  Our case highlights the rare but important occurrence of AV conduction defects and SA blocks due to thyrotoxicosis. 
Treatment of AV block requires correction of thyroid status and achieving euthyroid state along with careful electrolyte replacement. 
Temporary pacing may be required in symptomatic AV block however permanent pacemaker placement is usually not needed in these 
patients.
